Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lopez, Anastasia M."'
Autor:
Mahadevan, Krishnan K., McAndrews, Kathleen M., LeBleu, Valerie S., Yang, Sujuan, Lyu, Hengyu, Li, Bingrui, Sockwell, Amari M., Kirtley, Michelle L., Morse, Sami J., Moreno Diaz, Barbara A., Kim, Michael P., Feng, Ningping, Lopez, Anastasia M., Guerrero, Paola A., Paradiso, Francesca, Sugimoto, Hikaru, Arian, Kent A., Ying, Haoqiang, Barekatain, Yasaman, Sthanam, Lakshmi Kavitha, Kelly, Patience J., Maitra, Anirban, Heffernan, Timothy P., Kalluri, Raghu
Publikováno v:
In Cancer Cell 11 September 2023 41(9):1606-1620
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dilly J; Dana-Farber Cancer Institute, Boston, MA, United States., Hoffman MT; Dana-Farber Cancer Institute, Boston, MA, United States., Abbassi L; Dana-Farber Cancer Institute, Boston, MA, United States., Li Z; Dana-Farber Cancer Institute, Boston, MA, United States., Paradiso F; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Parent BD; Dana-Farber Cancer Institute, Boston, MA, United States., Hennessey CJ; Dana-Farber Cancer Institute, Boston, MA, United States., Jordan AC; Dana-Farber Cancer Institute, Boston, MA, United States., Morgado M; Dana-Farber Cancer Institute, Boston, MA, United States., Dasgupta S; Broad Institute, Cambridge, MA, United States., Uribe GA; Dana-Farber Cancer Institute, Boston, MA, United States., Yang A; Dana-Farber Cancer Institute, Boston, MA, United States., Kapner KS; Dana-Farber/Harvard Cancer Center, Boston, United States., Hambitzer FP; Dana-Farber Cancer Institute, Boston, MA, United States., Qiang L; Dana-Farber Cancer Institute, Boston, United States., Feng H; Dana-Farber Cancer Institute, Boston, United States., Geisberg J; Dana-Farber Cancer Institute, Boston, MA, United States., Wang J; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, United States., Evans KE; Dana-Farber Cancer Institute, Boston, MA, United States., Lyu H; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Schalck A; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Feng N; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lopez AM; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Bristow CA; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kim MP; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Rajapakshe KI; The University of Texas MD Anderson Cancer Center, United States., Bahrambeigi V; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Roth JA; Broad Institute, Cambridge, MA, United States., Garg K; Resolution Bioscience, United States., Guerrero PA; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Stanger BZ; University of Pennsylvania, Philadelphia, Pennsylvania, United States., Cristea S; Dana-Farber Cancer Institute, Boston, United States., Lowe SW; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Baslan T; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Van Allen EM; Dana-Farber Cancer Institute, Boston, MA, United States., Mancias JD; Dana-Farber Cancer Institute, Boston, MA, United States., Chan E; Amgen (United States), Thousand Oaks, CA, United States., Anderson A; Amgen Inc., Thousand Oaks, CA, United States., Katlinskaya YV; Amgen Inc., Thousand Oaks, CA, United States., Shalek AK; Massachusetts Institute of Technology, Cambridge, MA, United States., Hong DS; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States., Pant S; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hallin J; Mirati Therapeutics (United States), San Diego, CA, United States., Anderes K; Mirati Therapeutics (United States), San Diego, CA, United States., Olson P; Mirati Therapeutics (United States), San Diego, CA, United States., Heffernan TP; The University of Texas MD Anderson Cancer Center, Houston, United States., Chugh S; Dana-Farber Cancer Institute, Boston, MA, United States., Christensen JG; Mirati Therapeutics (United States), San Diego, CA, United States., Maitra A; The University of Texas MD Anderson Cancer Center, United States., Wolpin BM; Dana-Farber/Harvard Cancer Center, Boston, MA, United States., Raghavan S; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Nowak JA; Brigham and Women's Hospital, Boston, MA, United States., Winter PS; Massachusetts Institute of Technology, Cambridge, MA, United States., Dougan SK; Dana-Farber Cancer Institute, Boston, MA, United States., Aguirre AJ; Dana-Farber Cancer Institute, Boston, MA, United States.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Jul 08. Date of Electronic Publication: 2024 Jul 08.
Autor:
Mahadevan KK, McAndrews KM, LeBleu VS, Yang S, Lyu H, Li B, Sockwell AM, Kirtley ML, Morse SJ, Moreno Diaz BA, Kim MP, Feng N, Lopez AM, Guerrero PA, Sugimoto H, Arian KA, Ying H, Barekatain Y, Kelly PJ, Maitra A, Heffernan TP, Kalluri R
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Feb 18. Date of Electronic Publication: 2023 Feb 18.